Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Nanometrics Incorporated (NANO): Hedge Funds Are Bullish and Insiders Are Bearish, What Should You Do?

Page 1 of 2

Nanometrics Incorporated (NASDAQ:NANO) investors should be aware of an increase in support from the world’s most elite money managers of late.

Nanometrics Incorporated (NASDAQ:NANO)

In the financial world, there are many methods shareholders can use to track publicly traded companies. A couple of the most underrated are hedge fund and insider trading movement. At Insider Monkey, our studies have shown that, historically, those who follow the best picks of the best money managers can outperform the broader indices by a very impressive margin (see just how much).

Equally as integral, positive insider trading sentiment is a second way to break down the marketplace. As the old adage goes: there are a number of reasons for a bullish insider to drop shares of his or her company, but just one, very clear reason why they would initiate a purchase. Plenty of empirical studies have demonstrated the market-beating potential of this method if investors know what to do (learn more here).

Now, it’s important to take a look at the latest action encompassing Nanometrics Incorporated (NASDAQ:NANO).

How have hedgies been trading Nanometrics Incorporated (NASDAQ:NANO)?

Heading into 2013, a total of 7 of the hedge funds we track were long in this stock, a change of 17% from the previous quarter. With hedge funds’ sentiment swirling, there exists a few noteworthy hedge fund managers who were boosting their stakes considerably.

According to our comprehensive database, Chuck Royce’s Royce & Associates had the largest position in Nanometrics Incorporated (NASDAQ:NANO), worth close to $23.3 million, comprising 0.1% of its total 13F portfolio. Coming in second is Gotham Asset Management, managed by Joel Greenblatt, which held a $1.4 million position; the fund has 0.1% of its 13F portfolio invested in the stock. Other hedge funds with similar optimism include Steve Shapiro’s Intrepid Capital Management Inc DE, Israel Englander’s Millennium Management and John Overdeck and David Siegel’s Two Sigma Advisors.

Now, key hedge funds have been driving this bullishness. Millennium Management, managed by Israel Englander, established the largest position in Nanometrics Incorporated (NASDAQ:NANO). Millennium Management had 0.6 million invested in the company at the end of the quarter. John Overdeck and David Siegel’s Two Sigma Advisors also initiated a $0.4 million position during the quarter.

Insider trading activity in Nanometrics Incorporated (NASDAQ:NANO)

Insider purchases made by high-level executives is particularly usable when the company in question has experienced transactions within the past 180 days. Over the last half-year time period, Nanometrics Incorporated (NASDAQ:NANO) has experienced zero unique insiders purchasing, and 1 insider sales (see the details of insider trades here).

Let’s also review hedge fund and insider activity in other stocks similar to Nanometrics Incorporated (NASDAQ:NANO). These stocks are ChipMOS Technologies (Bermuda) Ltd (NASDAQ:IMOS), Enphase Energy Inc (NASDAQ:ENPH), Ambarella Inc (NASDAQ:AMBA), LTX-Credence Corp (NASDAQ:LTXC), and Rda Microelectronics Inc (ADR) (NASDAQ:RDA). This group of stocks belong to the semiconductor equipment & materials industry and their market caps are similar to NANO’s market cap.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!